Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin vs Pioglitazone for Menstrual Irregularities and Hyperandrogenism in PCOS
NCT03757923Phase 2Unknown
- Sponsor
- Dow University of Health Sciences
- Start
- Jun 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin, pioglitazone in polycystic ovary syndrome (PCOS), sponsored by Dow University of Health Sciences. Status: unknown.
02
Drugs
metforminpioglitazone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03757923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03757923.